G. Achniotou

Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets

A. Haycox, S. Simoens, B. Wettermark, 2018, Front. Public Health.

The Expiry of Humira

I. Huys, E. Allocati, A. Vulto, 2021 .

The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures

I. Huys, E. Allocati, A. Vulto, 2020, Frontiers in Pharmacology.